Department of Otolaryngology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Int Forum Allergy Rhinol. 2020 Feb;10(2):208-216. doi: 10.1002/alr.22491. Epub 2019 Nov 21.
Olfactory dysfunction is one of the common symptoms of eosinophilic chronic rhinosinusitis (ECRS), for which endoscopic sinus surgery (ESS) is the standard treatment. Although the success rates of ESS for restoring olfaction in CRS have been reported, those for ECRS, as defined by new Japanese diagnostic criteria, remain unclear and the parameters affecting improvement rates have not yet been identified.
Eighty-four patients with ECRS who underwent full-house ESS were retrospectively investigated. Olfactory function was examined using T&T recognition thresholds before and 3 months after surgery.
The total positive improvement rate in olfaction was 76.2% (64 of 84) and the mean T&T recognition threshold decreased significantly from 5.2 ± 1.1 to 3.0 ± 1.8 after surgery (p < 0.001). Some factors, including negative intravenous olfaction test, presence of olfactory cleft (OC) lesions, a history of sinus surgery, age ≥ 45 years, and being male, were more frequent in the olfaction refractory group. Furthermore, improvement of the T&T recognition threshold was significantly lower for factors of negative intravenous olfaction testing, the presence of OC lesions, and being male. Age and the proportion of blood eosinophils correlated with improvement.
Herein we examined prognostic factors for olfactory outcomes in ECRS treated with ESS. The intravenous olfaction test, presence of OC lesions, sex differences, and age (the cut-off value was 45 years) were identified as independent prognostic factors for olfactory outcomes 3 months after surgery.
嗅觉功能障碍是嗜酸性慢性鼻-鼻窦炎(ECRS)的常见症状之一,内镜鼻窦手术(ESS)是其标准治疗方法。尽管已有报道称 ESS 可成功恢复 CRS 的嗅觉,但对于新的日本诊断标准定义的 ECRS,其成功率仍不清楚,也尚未确定影响改善率的参数。
回顾性调查了 84 例接受全鼻窦 ESS 的 ECRS 患者。手术前后使用 T&T 识别阈值检查嗅觉功能。
嗅觉总阳性改善率为 76.2%(84 例中有 64 例),术后 T&T 识别阈值从 5.2±1.1 显著降低至 3.0±1.8(p<0.001)。嗅觉无改善组中,静脉嗅觉测试阴性、嗅裂病变、鼻窦手术史、年龄≥45 岁和男性等因素更为常见。此外,静脉嗅觉测试阴性、嗅裂病变和男性等因素的 T&T 识别阈值改善明显较低。年龄和血嗜酸性粒细胞比例与改善相关。
本研究检查了 ESS 治疗 ECRS 后嗅觉结果的预后因素。静脉嗅觉测试、嗅裂病变、性别差异和年龄(截值为 45 岁)被确定为术后 3 个月嗅觉结果的独立预后因素。